Complies with American College of Rheumatology (ACR) ANA Position Statement. According to the ACR, the immunofluorescence antinuclear antibody (ANA) assay is the gold standard for ANA testing with greater sensitivity than solid phase assays.
HEp-2 cells have approximately 100 to 150 possible autoantigens. These cells are used to detect ANAs by the immunofluorescence (IF) method, in which both pattern and titer can be described, and to display a variety of autoantigens not present in multiplex ANA tests.
The assay is a tool in the differential diagnosis of systemic rheumatic diseases like systemic lupus erythematosus (SLE), mixed connective tissue diseases (MCTD), scleroderma, Sjögren`s syndrome, polymyositis and dermatomyositis.
Automation friendly with common reagents and protocolsHELIOS®HELMED®Easy handling: ready to use components that fit directly in the HELMED®/HELIOS® racksUnique mounting medium that allows full automationPattern library with real AESKUSLIDES cells and substrates
The “ONE” AESKU® CONCEPTImprove your lab throughput and reduce diagnosis timeOne incubation temperatureOne incubation timeOne buffer system (Sample & Wash)One mounting medium (suitable for use with the HELMED and HELIOS)One counterstain
Improve your laboratory accreditation by adding traceability to your slides.
The AESKUSLIDES masks have standard product and lot information, as well as a unique serial number in the barcode that allows traceability.
Information contained in the barcode:
Reference / catalog numberSubstrateLot numberSlide unique serial number FDA 501(k) #: K120889